MOTO CENTRAL LIMITED

Company number 07820060 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: B-

Moto Central Limited is operational with a strengthening cash position, but suffers from chronic equity erosion and a heavy reliance on inventory to meet short-term obligations. Like a patient with a stable pulse but a lingering underlying condition, the business is surviving but not thriving—evidenced by consistently shrinking net assets and mounting accumulated losses.


Key Vital Signs

1. Pulse (Cash & Liquidity) * Cash at Bank: £182,364 (Up 77% from £102,832 in 2023) * Current Ratio: 1.12 (Current Assets £787k / Current Liabilities £700k) * Quick Ratio: 0.66 (Excluding stock of £325k from current assets) * Interpretation: The patient's pulse is getting stronger. Cash levels have improved significantly year-on-year. However, the current ratio is barely above 1, and the quick ratio is below 1, meaning that if the business couldn't sell its stock, it would struggle to pay its immediate debts.

2. Blood Pressure (Debt & Liabilities) * Total Liabilities: £727,842 (Current: £700,550; Long-term: £27,292) * Secured Bank Loans: £63,908 (Up from £27,800 in 2023, secured by a personal guarantee from the director) * Trade Creditors: £411,939 * Interpretation: Blood pressure is slightly elevated. The business relies heavily on trade creditors to finance its operations. More concerning is the sharp increase in bank loans, which are secured against the director's personal assets—a risky position that ties the director's personal financial health directly to the company's heartbeat.

3. Cholesterol (Asset Quality & Accumulated Losses) * Goodwill: £300,000 (Out of £354k total fixed assets) * Accumulated P&L Loss: (£199,619) * Net Assets: £413,668 (Down from £542,638 in 2020) * Interpretation: The company has high "bad cholesterol" in the form of intangible goodwill, which makes up the vast majority of its fixed assets and is amortizing by £60,000 annually. Meanwhile, the accumulated P&L reserve is deeply in the red and worsening, indicating that historical losses are clogging the company's financial arteries.


Diagnosis

Chronic Equity Erosion with Acute Liquidity Constraints

The financial data reveals a business suffering from a slow but persistent bleed of shareholder value. Over the past four years, net assets have steadily declined from £542k to £413k. This erosion is a symptom of trading losses that have pushed the Profit & Loss reserve to nearly (£200k).

While the company has improved its cash position, this appears to have been achieved by increasing its overdraft and bank loan facilities (which carry the added risk of a personal guarantee from the director, Mr. Neil Bell) and stretching trade creditors. The business is heavily reliant on selling motorcycle gear (stock represents 41% of total current assets) to keep up with its short-term liabilities. Additionally, the director has an overdrawn loan account of £5,041, which represents an unsecured, interest-free withdrawal of company capital.

The overall prognosis is guarded. The patient is not in immediate critical condition (administration or liquidation), as cash is available and the business is actively trading with 18 employees. However, without treating the underlying lack of profitability, the company will continue to lose financial muscle mass (net assets). The increasing reliance on personally guaranteed bank debt means that if the business catches a sudden cold (like a drop in retail sales or supply chain delays), it could quickly escalate into a severe financial emergency for both the company and the director.


Recommendations

  1. Stop the Bleeding (Profitability Focus): The primary treatment must be returning the company to net profitability. Management should review pricing strategies, supplier costs, and operating overheads to ensure the business generates more revenue than it spends. Halting the growth of accumulated losses is vital.
  2. Improve Cardiovascular Health (Working Capital Management): With a quick ratio of 0.66, the business needs to accelerate the conversion of stock and debtors into cash. Consider running targeted promotions to clear excess stock and tighten credit terms for customers to bring cash in faster.
  3. Reduce Toxicity (Director Loan & Personal Guarantees): The director should repay the £5,041 overdrawn loan account to strengthen the balance sheet and set a disciplined example of capital management. Furthermore, the business should aim to reduce its reliance on personally guaranteed bank loans to protect the director's personal assets from business risks.
  4. Monitor Cholesterol (Goodwill): The £300k goodwill is a legacy of past acquisitions. While it is being written off systematically, management must ensure that the underlying business operations are generating sufficient real, tangible equity to offset this annual £60k amortisation charge.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 29 July 2026